ICU Medical Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名45/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价181.40。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
ICU Medical Inc评分
相关信息
行业排名
45 / 206
全市场排名
132 / 4560
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
6
位分析师
买入
评级
181.400
目标均价
+26.17%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
ICU Medical Inc亮点
亮点风险
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
公司代码ICUI
公司ICU Medical Inc
CEOJain (Vivek)
网址https://www.icumed.com/
常见问题
ICU Medical Inc(ICUI)的当前股价是多少?
ICU Medical Inc(ICUI)的当前股价是 142.670。
ICU Medical Inc的股票代码是什么?
ICU Medical Inc的股票代码是ICUI。
ICU Medical Inc股票的52周最高点是多少?
ICU Medical Inc股票的52周最高点是175.510。
ICU Medical Inc股票的52周最低点是多少?
ICU Medical Inc股票的52周最低点是107.000。
ICU Medical Inc的市值是多少?
ICU Medical Inc的市值是3.52B。
ICU Medical Inc的净利润是多少?
ICU Medical Inc的净利润为-117.69M。
现在ICU Medical Inc(ICUI)的股票是买入、持有还是卖出?
根据分析师评级,ICU Medical Inc(ICUI)的总体评级为买入,目标价格为181.400。